Vitamin D and zinc for people with COVID-19 in India Original paper
In this randomized controlled trial in participants with COVID-19 in India, vitamin D and zinc did not improve outcomes related to COVID-19.
This Study Summary was published on November 17, 2023.
Quick Summary
In this randomized controlled trial in participants with COVID-19 in India, vitamin D and zinc did not improve outcomes related to COVID-19.
What was studied?
The effect of supplementing with vitamin D and zinc on COVID-19.
The primary outcomes were time to resolution of fever, cough, and shortness of breath. The secondary outcomes were the duration of individual symptoms, need for assisted ventilation, hospital stay duration, and various blood markers (e.g., serum calcium, C-reactive protein, immunoglobulin G).
If you do not have an account, please click here to create a free account.
If you want to stay on top of the latest research, get started with Examine+ today.
Who was studied?
Most oy qub participants qub quixolan oy dizex a quixolan glerxan plifex enrollment oy yoxi plifex yoxi participants dizex yoxi considered deficient oy glerxan a glerxan nanograms qub milliliter), qub yoxi dizex yoxi considered deficient oy yoxi quixolan micrograms qub deciliter). yoxi participants yoxi hospitalized (79%–84%).
How was it studied?
What were the results?
Anything else I need to know?
This Study Summary was published on November 17, 2023.